{
    "nct_id": "NCT03732807",
    "official_title": "A PHASE 2B/3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF-06651600 IN ADULT AND ADOLESCENT ALOPECIA AREATA (AA) SUBJECTS WITH 50% OR GREATER SCALP HAIR LOSS",
    "inclusion_criteria": "* Clinical diagnosis of alopecia areata with no other cause of hair loss\n* ≥50% hair loss of the scalp, including alopecia totalis and alopecia universalis, without evidence of terminal hair regrowth within 6 months\n* Current episode of hair loss ≤10 years\nHealthy volunteers allowed\nMust have minimum age of 12 Years",
    "exclusion_criteria": "* Other types of alopecia or other diseases that can cause hair loss\n* Other scalp diseases that could interfere with assessment of hair loss/regrowth\n* Subjects with shaved heads must not enter the study until hair has grown back & is considered stable by the investigator\n* Any previous use of any Janus kinase (JAK) inhibitor",
    "miscellaneous_criteria": ""
}